Guardant Health (GH) reported $281.27 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 39.4%. EPS of -$0.50 for the same period compares to -$0.62 a year ago.The reported revenue represents a surprise of +0.47% over the Zacks Consensus Estimate of $279.96 million. With the consensus EPS estimate being -$0.42, the EPS surprise was -18.12%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...

For the quarter ended December 2025, Chemours (CC) reported revenue of $1.33 billion, down 2.2% over the same period last year. EPS came in at $0.05, compared to $0.11 in the year-ago quarter.The reported revenue represents no surprise over the Zacks Consensus Estimate of $1.33 billion. With the consensus EPS estimate being $0, the EPS surprise was +2400%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, so ...

Core Insights - Nordson reported revenue of $669.46 million for the quarter ended January 2026, reflecting an 8.8% increase year-over-year and a surprise of +2.86% over the Zacks Consensus Estimate of $650.83 million [1] - The company's EPS for the quarter was $2.37, up from $2.06 in the same quarter last year, with an EPS surprise of +0.53% compared to the consensus estimate of $2.36 [1] Financial Performance Metrics - Net Sales for Industrial Precision Solutions reached $326.86 million, exceeding the average estimate of $308.5 million by two analysts, representing an 8.8% year-over-year increase [4] - Net Sales for Advanced Technology Solutions were reported at $149.42 million, surpassing the estimated $138 million by two analysts, showing a significant year-over-year increase of 23.1% [4] - Net Sales for Medical and Fluid Solutions amounted to $193.18 million, slightly below the average estimate of $204 million, indicating a minor year-over-year decline of 0.2% [4] Stock Performance - Over the past month, Nordson's shares have returned +11.6%, contrasting with a -1.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Cadence Design Systems (CDNS) reported $1.44 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 6.2%. EPS of $1.99 for the same period compares to $1.88 a year ago.The reported revenue represents a surprise of +1.12% over the Zacks Consensus Estimate of $1.42 billion. With the consensus EPS estimate being $1.90, the EPS surprise was +4.57%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations t ...

Core Insights - Yelp reported revenue of $359.99 million for the quarter ended December 2025, a decrease of 0.5% year-over-year, with EPS at $0.61 compared to $0.62 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $358.21 million by 0.5%, while the EPS surprised by 29.1% against the consensus estimate of $0.47 [1] Financial Performance Metrics - Yelp's shares have declined by 20.5% over the past month, contrasting with a -0.3% change in the Zacks S&P 500 composite [3] - The company holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3] Advertising Metrics - Total Paying Advertising Locations were reported at 496 thousand, slightly below the average estimate of 502.67 thousand [4] - Paying Advertising Locations for Restaurants, Retail & Other remained at 246 thousand, matching the average estimate [4] - Paying Advertising Locations for Services were reported at 250 thousand, below the average estimate of 256.67 thousand [4] - Net revenue from Advertising was $338.21 million, slightly below the average estimate of $339.01 million, reflecting a year-over-year decline of 2.2% [4] - Net revenue from Other services was $21.78 million, exceeding the estimated $19.2 million, marking a year-over-year increase of 33.5% [4] - Advertising revenue from Services was $231.38 million, slightly above the average estimate of $231.01 million, with a year-over-year increase of 2.9% [4] - Advertising revenue from Restaurants, Retail & Other was reported at $106.83 million, below the average estimate of $108 million, showing a year-over-year decline of 11.6% [4]

Core Insights - Confluent reported revenue of $314.82 million for the quarter ended December 2025, reflecting a year-over-year increase of 20.5% and surpassing the Zacks Consensus Estimate of $307.29 million by 2.45% [1] - The company's EPS for the quarter was $0.12, an increase from $0.09 in the same quarter last year, and exceeded the consensus EPS estimate of $0.10 by 22.08% [1] Revenue Breakdown - Revenue from Services was $13.17 million, exceeding the average estimate of $10.96 million by analysts, representing a year-over-year growth of 24.5% [4] - Subscription revenue reached $301.65 million, surpassing the average estimate of $295.97 million, with a year-over-year increase of 20.4% [4] - Revenue from Confluent Cloud was $169 million, above the average estimate of $165.22 million, showing a year-over-year growth of 22.5% [4] Stock Performance - Over the past month, Confluent's shares have returned +0.6%, while the Zacks S&P 500 composite has seen a decline of -0.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Amazon reported revenue of $213.39 billion for the quarter ended December 2025, reflecting a year-over-year increase of 13.6% and a surprise of +0.91% over the Zacks Consensus Estimate of $211.46 billion [1] - The earnings per share (EPS) for the quarter was $1.95, slightly below the consensus estimate of $1.98, resulting in an EPS surprise of -1.52% [1] Revenue Performance - Subscription services saw a year-over-year change of +12%, exceeding the average estimate of +10.8% [4] - Physical stores reported a +5% change compared to the estimated +4.8% [4] - Amazon Web Services (AWS) net sales grew by +24%, surpassing the average estimate of +21.8% [4] - Third-party seller services experienced a +10% change, close to the average estimate of +10.7% [4] Net Sales Breakdown - AWS net sales reached $35.58 billion, exceeding the estimated $35.03 billion, representing a +23.6% change year-over-year [4] - Physical stores generated $5.86 billion in net sales, slightly below the estimated $5.88 billion, with a +5% year-over-year change [4] - Online stores reported net sales of $82.99 billion, above the estimated $82.4 billion, marking a +9.8% change [4] - Subscription services net sales were $13.12 billion, exceeding the average estimate of $12.86 billion, reflecting a +14% year-over-year change [4] - North America net sales totaled $127.08 billion, slightly below the estimate of $127.14 billion, with a +10% year-over-year change [4] - Advertising services net sales reached $21.32 billion, surpassing the estimated $21.21 billion, representing a +23.3% change [4] - International net sales were $50.72 billion, exceeding the estimated $49.34 billion, with a +16.8% year-over-year change [4] - Third-party seller services net sales were $52.82 billion, above the average estimate of $52.27 billion, reflecting a +11.2% year-over-year change [4] Stock Performance - Amazon's shares have returned -3.6% over the past month, while the Zacks S&P 500 composite has increased by +0.5% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Financial Performance - For the quarter ended December 2025, Rexford Industrial reported revenue of $248.1 million, reflecting a year-over-year increase of 2.1% [1] - Earnings per share (EPS) for the quarter was $0.59, a significant increase from $0.27 in the same quarter last year [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $250.22 million, resulting in a revenue surprise of -0.85% [1] - The company achieved an EPS surprise of +1.01%, with the consensus EPS estimate being $0.58 [1] Key Metrics - Rental income was reported at $243.23 million, compared to the average estimate of $247.13 million, representing a year-over-year change of +1.5% [4] - Management and leasing services revenue was $0.2 million, exceeding the average estimate of $0.12 million, with a year-over-year increase of +18% [4] - Interest income was reported at $4.67 million, below the average estimate of $6.07 million, but showed a substantial year-over-year increase of +56.1% [4] - Net earnings per share (diluted) was reported at -$0.30, compared to the average estimate of $0.26 [4] Stock Performance - Shares of Rexford Industrial have returned +4.5% over the past month, outperforming the Zacks S&P 500 composite's +0.9% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - MetLife reported $24.19 billion in revenue for Q4 2025, a year-over-year increase of 22.6%, with EPS of $2.58 compared to $2.08 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $30.04 billion, resulting in a surprise of -19.47%, while the EPS exceeded expectations by 9.32% [1] Financial Performance Metrics - Adjusted Revenue from Asia's net investment income was $1.41 billion, exceeding the estimated $1.38 billion, reflecting a 12.3% year-over-year increase [4] - Adjusted Revenue from Latin America's premiums reached $1.44 billion, surpassing the $1.24 billion estimate, marking a 31.4% year-over-year growth [4] - Adjusted Revenue from Asia's premiums was $1.22 billion, slightly below the $1.23 billion estimate, showing a 1.3% year-over-year increase [4] - Adjusted Revenue from EMEA's premiums was $679 million, exceeding the $627.25 million estimate, with a year-over-year change of 19.5% [4] - Total revenue from net investment income was $5.92 billion, above the $5.5 billion estimate, representing a 9.6% year-over-year increase [4] - Other revenues amounted to $737 million, surpassing the $661.92 million estimate, with a year-over-year change of 15% [4] - Universal life and investment-type product policy fees generated $1.27 billion, slightly above the $1.26 billion estimate, reflecting a 4.2% year-over-year increase [4] - Total adjusted revenue for Group Benefits was $6.65 billion, slightly below the $6.71 billion estimate, with a year-over-year change of 2.3% [4] - Adjusted Revenue for Retirement & Income Solutions from universal life and investment-type product policy fees was $104 million, exceeding the $98.69 million estimate, marking a 5.1% year-over-year increase [4] - Adjusted Revenue for Retirement & Income Solutions from net investment income was $2.23 billion, above the $2.19 billion estimate, reflecting a 4% year-over-year increase [4] - Adjusted Revenue for Retirement & Income Solutions from other revenues was $75 million, surpassing the $62.52 million estimate, with a year-over-year change of 23% [4] Stock Performance - MetLife's shares have returned -5.3% over the past month, while the Zacks S&P 500 composite increased by 0.9% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance compared to the broader market in the near term [3]

Core Insights - McKesson reported revenue of $106.16 billion for the quarter ended December 2025, reflecting an 11.4% increase year-over-year and surpassing the Zacks Consensus Estimate of $105.66 billion by 0.47% [1] - The company's EPS for the quarter was $9.34, up from $8.03 in the same quarter last year, also exceeding the consensus EPS estimate of $9.31 by 0.35% [1] Revenue Performance - Medical-Surgical Solutions revenue was $2.99 billion, slightly below the average estimate of $3.05 billion, with a year-over-year increase of 1.4% [4] - Prescription Technology Solutions revenue matched the average estimate at $1.5 billion, showing a year-over-year growth of 9.4% [4] - Other revenue reached $335 million, exceeding the estimated $297.61 million [4] - North American Pharmaceutical revenue was $88.32 billion, slightly below the average estimate of $88.6 billion, with a year-over-year increase of 1.4% [4] - Oncology & Multispecialty revenue was $13.01 billion, surpassing the average estimate of $12.48 billion [4] Adjusted Operating Profit - Adjusted Operating Profit for Medical-Surgical Solutions was $265 million, below the estimate of $278.29 million [4] - Adjusted Operating Profit for Prescription Technology Solutions was $277 million, exceeding the average estimate of $264.4 million [4] - Adjusted Operating Profit for Oncology & Multispecialty was $366 million, above the average estimate of $353.98 million [4] - Adjusted Operating Profit for Corporate was -$156 million, better than the estimate of -$180.91 million [4] - Adjusted Operating Profit for North American Pharmaceutical was $872 million, exceeding the average estimate of $855.24 million [4] - Adjusted Operating Profit for Other was $28 million, surpassing the average estimate of $14.6 million [4] Stock Performance - McKesson's shares have returned 3% over the past month, outperforming the Zacks S&P 500 composite's return of 0.9% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]